We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.50
Ask: 57.50
Change: 1.00 (1.77%)
Spread: 2.00 (3.604%)
Open: 56.50
High: 57.50
Low: 56.50
Prev. Close: 56.50
BSC Live PriceLast checked at -
British Smaller Companies VCT 2 is an Investment Trust

To create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

15 Mar 2024 12:15

RNS Number : 0794H
British Smaller Companies VCT2 Plc
15 March 2024
 

£ British Smaller Companies VCT2 plc

Annual Financial Report Announcement

for the year ended 31 December 2023

 

British Smaller Companies VCT2 plc (the "Company") today announces its audited results for the year ended 31 December 2023.

HIGHLIGHTS

l

4.8 per cent return on opening net assets, driven by underlying revenue growth in portfolio companies.

l

Total Return increased by 2.95 pence to 145.55 pence per share, net asset value at 31 December 2023 of 59.3 pence per share (2022: 61.6 pence per share).

l

Realisations generated total proceeds of £4.1 million in the year, a gain of £1.1 million over the opening carrying value and £0.8 million over cost. Three full or partial exits post-year-end generating cumulative proceeds of £6.5 million, including the realisation of Displayplan, which returned 9.6x cost over the life of the Company's investment. 

l

Four new investments and five follow-on investments totalling £10.0 million completed during the year. Three follow-on investments of £1.2 million made subsequent to the year end.

l

Total dividends paid during the year ended 31 December 2023 of 5.25 pence per share (2022: 3.0 pence per share), bringing total cumulative dividends paid since inception to 86.25 pence per share at 31 December 2023 (2022: 81.0 pence per share).

l

£27.5 million raised in fully subscribed November 2022 offer, with shares allotted in April 2023. Gross applications of £34.5 million received in relation to September 2023 offer, with £11.4 million allotted in January 2024 and the remaining funds to be allotted in early April 2024.

l

The Board is declaring an interim dividend of 1.5 pence per share in respect of the year ending 31 December 2024. The dividend will be paid on 28 June 2024 to shareholders on the register on 31 May 2024.

 

Chair's Statement

 

?I am pleased to present the 2023 annual report and financial statements of British Smaller Companies VCT2 plc (the "Company"), which highlight a robust performance in a year of macroeconomic and geopolitical headwinds.

 

The year began with inflation remaining persistently high, with businesses and consumers alike struggling with high prices for energy, food and other goods and services. To combat this, interest rates continued their march upwards, from 3.5 per cent at the start of the year to reach 5.25 per cent by August. Market conditions stabilised in the second half of the year, with the rate of inflation starting to ease. With the expectation that interest rates will begin to decrease at some point in 2024, market sentiment towards growth-focused investments has improved, which fed through to an increase in market multiples, used to value the Company's investments, in the final quarter of the year.

 

Through this challenging period it was pleasing to see the positive performance of the Company, which generated a 4.8 per cent return on its opening net asset value in the year. Over the same period, the FTSE Small Cap rose by 3.0 per cent, while the AIC's index of generalist VCTs reduced by 1.3 per cent on a Share Price Total Return basis.

 

This return has been driven by two continuing trends. First, portfolio companies have adapted well to market conditions and, while focused on capital efficiency, are still achieving good growth rates in most cases. Of the 23 companies valued on a revenue basis, all but four have demonstrated positive revenue growth over the last 12 months, with eight delivering growth of over 40 per cent. This growth has helped to offset the impact of lower valuation multiples at the start of the year, and leaves the portfolio well placed for further growth as market conditions improve.

 

Second, the portfolio continues to achieve positive realisations in a market where many firms have struggled to convert book values into cash. In the year the Company exited four investments for combined proceeds of £4.1 million; these were pleasing outcomes for the Company following challenging hold periods for all of these assets, and reflects the Company's ethos of working closely with management teams to generate positive returns from all of its investments.

 

Financial Performance

In 2023, the Company delivered a 2.95 pence per ordinary share increase in Total Return, equivalent to 4.8 per cent of the opening net asset value at 31 December 2022. Total Return is now 145.55 pence per ordinary share.

 

This was driven by the portfolio, which generated a return of £9.1 million, 11.2 per cent over its opening value, of which £1.1 million was realised and £8.0 million unrealised. New and follow-on investments totalling £10.0 million were completed.

 

Realisations in the Year

Realisations of portfolio investments generated total proceeds of £4.1 million, a gain of £1.1 million over the opening carrying value and £0.8 million over the original cost. There were four realisations in the year: Wakefield Acoustics, Ncam, E2E and MacroArt.

 

Wakefield Acoustics was realised in January, generating proceeds of £0.7 million and an overall return of 1.5x cost. The investment in Ncam was realised in April, generating initial proceeds of £0.9 million, with the potential for additional receipts of up to £0.8 million of deferred proceeds over the coming years, which would see the Company fully recover its investment. £0.2 million of deferred proceeds have been recognised at the period end.

 

In November the Company exited its investment in E2E for £1.3 million, representing a 2.5x return on the Company's cost; and MacroArt for £1.0 million, representing a 2.0x return on cost. 

 

The Company has seen further realisations post-year-end, partially realising its investments in KeTech and Arcus in January 2024, and fully exiting its investment in Displayplan in February 2024, all at valuations in line with fair value at 31 December 2023, and delivering a net realised gain of £5.5 million.

 

To maximise shareholder value, the KeTech business was split into its two component parts, Rail and Defence. The Defence business was subsequently sold in January 2024, generating proceeds of £1.5 million. To date, the Company has realised proceeds of £4.1 million from its KeTech investment, a 2.0x return on cost, while still retaining its investment in the Rail Business, which at year-end was valued at £1.3 million.

 

In February 2024, the Company sold its investment in Displayplan for £4.8 million. Total proceeds received over the life of the investment are £6.7 million, an excellent 9.6x return on the Company's cost. There is the potential for further deferred proceeds in due course. The case study on page 24 of the annual report provides further information on this investment.

 

Arcus was partially exited in January 2024. The Company received initial proceeds of £0.2 million, with the potential for additional receipts as the company develops.

 

New Investments

The Company invested £10.0 million in the year. Four new investments were completed, totalling £6.9 million. In our continued support of the portfolio, five companies received follow-on funding, totalling £3.1 million in aggregate. This follow-on investment was lower than the prior year as portfolio companies focused on capital efficiency, but it is expected that the level of follow-on investment will increase again in 2024.

 

The new investments in 2023 were:

 

Investment Sector

DrDoctor Patient engagement and communications software platform

GEEIQ Data and market intelligence platform in the gaming space

Workbuzz SaaS based employee engagement, survey and insights platform

Xapien Automated background research software

 

Treasury

Due to the nature of its structure, a proportion of the Company's net assets will be held in cash and cash equivalents at any point in time. As interest rates have risen, the Company has taken an active approach to generating a good return on liquid funds, whilst remaining focused on the primary goal of capital preservation. 

 

A portion of the Company's liquid assets are held across a diversified range of Triple-A rated money market funds, managed by global institutions, while the balance is held as readily accessible cash, all of which is held at Tier 1 Financial Institutions (A2 rated or above).

 

The Company's small externally managed listed portfolio was exited in the period.

 

In the year, the Company generated a return of £1.4 million on its liquid assets, and at year-end was generating a weighted run-rate return on these assets of around 4.5 per cent per annum.

 

Financial Results

The movement in net asset value ("NAV") per ordinary share and the dividends paid are set out in the table below:

 

Pence per

ordinary share

£000

NAV at 31 December 2022

61.60

111,869

Increase in value

3.55

8,043

Gain on disposal of investments

0.45

1,018

Net underlying change in investment portfolio

4.00

9,061

Net operating costs

(0.35)

(769)

Incentive fee

(0.70)

(1,601)

Total Return in period

 

2.95

 

6,691

Issue/buy-back of new shares

-

28,012

NAV before the payment of dividends

64.55

146,572

Dividends paid

(5.25)

(10,956)

NAV at 31 December 2023

 

59.30

 

135,616

Cumulative dividends paid

86.25

Total Return:

 

 

at 31 December 2023

 

145.55

at 31 December 2022

142.60

 

?The charts on page 12 of the annual report show the movement in Total Return and net asset value over time in greater detail.

 

The investments held at the beginning of the financial year, amounting to £81.4 million, delivered a return over the year of £9.1 million.

 

The current portfolio's net valuation increased by £8.0 million. Within this there were valuation gains of £11.6 million, offset by £3.6 million of downward movements.

 

Following the portfolio's evolution towards younger, higher growth companies after changes to VCT regulations in 2015, as expected the level of income generated by the portfolio continues to decrease. Overall, £0.7 million was recognised in the year, down from £0.8 million in 2022.

 

Dividends

Dividends paid in the year totalled 5.25 pence per ordinary share. These comprised interim dividends of 5.25 pence per ordinary share for the year ended 31 December 2023. Cumulative dividends paid as at 31 December 2023 were 86.25 pence per ordinary share.

 

An interim dividend for the year ending 31 December 2024 of 1.5 pence per ordinary share will be paid on 28 June 2024, to shareholders on the register at 31 May 2024.

 

Dividend Re-investment Scheme ("DRIS")

The Company operates a DRIS, which gives shareholders the opportunity to re-invest any cash dividends; it is open to all shareholders, including those who invested under the recent offers. The main advantages of the DRIS are:

 

1 the dividends remain tax free; and

2 any DRIS investment attracts income tax relief at the rate of 30 per cent.

 

For the financial year ended 31 December 2023, £2.1 million was re-invested by way of the DRIS, from overall dividend proceeds of £11.0 million.

 

Liquidity and Fundraising

The Company completed a successful fundraise during the year, allotting £27.5 million in April 2023, relating to the 2022/23 tax year.

 

At 31 December 2023, the Company's cash and money market reserves of £39.1 million represented 28.8 per cent of net assets.

 

Post-period end, a further £11.4 million of shares were allotted, relating to the 2023/24 tax year. It is expected that a further c.£23.1 million will be allotted in early April 2024, following the close of the Company's joint share offer alongside British Smaller Companies VCT plc on 16 February 2024.

 

Board Changes

I am retiring as Chair at the end of this year's AGM. I am delighted to announce that I will be succeeded by Barbara Anderson, who has served as a director of the Company for three years.

 

Incentive Fee

Following discussions with YFM Private Equity Limited, the Company's Manager, an additional annual performance hurdle has been added to the Company's performance incentive fee, effective from 1 January 2024. Further details are available within Note 3.

 

Annual General Meeting

The Annual General Meeting of the Company will be held at 9:30 am on 13 June 2024 at

Thomas House, 84 Ecclestone Square, London SW1V 1PX. Full details of the agenda for this meeting are included in the Notice of the Annual General Meeting on page 90 of the annual report.

 

Investor Workshop

The annual shareholder workshop held on 20 June 2023 was well attended. Attendees heard from Tom Dunlop, CEO of Summize, and Philip Hunt, Chair of Vuealta.

 

We also hosted an event by video platform on 27 November 2023, which included presentations from Tom Whicher, CEO of DrDoctor, and Mal Barritt, CEO of TravelTek.

 

We are pleased to announce that the next in-person shareholder workshop will be held jointly with British Smaller Companies VCT plc on 20 June 2024 at One Great George Street, Westminster, London SW1P 3AA.

 

The electronic communications policy continues to be a success, with 83 per cent of shareholders now receiving communications in this way. Documents such as the annual report are published on the website www.bscfunds.com rather than by post, saving on printing costs, as well as being more environmentally friendly.

 

The Company's website, www.bscfunds.com, is refreshed on a regular basis and provides a comprehensive level of information in what I hope is a user-friendly format.

 

Post Balance Sheet Events

Subsequent to the year end, the Company has invested £1.2 million into three follow on investments. The Company also received £6.5 million from the realisation of Displayplan, and the partial realisations of KeTech and Arcus, as detailed above.

 

On 30 January 2024, the Company issued 19,533,372 shares in relation to the 2023/24 fundraising, raising gross proceeds of £11.4 million. Following this allotment, the Company's issued share capital consists of 248,292,037 ordinary shares with voting rights and 21,383,768 shares held in treasury.

 

Outlook

The final quarter of the year saw an improvement in the economic outlook, with rates of inflation declining and a growing expectation of interest rate cuts in 2024. However, we remain watchful for changes to this trend, as seen recently with disruptions to shipping in the Red Sea linked to the instability in the Middle East raising some concerns about rising input costs again. Upcoming elections in the UK and US in 2024 may also impact economic sentiment.

 

Portfolio companies continue to grow revenues in an efficient manner and are expected to be well placed to grow further as macroeconomic conditions improve. Equally, the Company's 2023/24 fundraising puts it in a strong position to continue to support the portfolio's growth, as well as adding new businesses through the coming year.

 

As I retire from the Board at the upcoming AGM, I am pleased with the position in which I leave the Company and wish it, and my Board colleagues, well for continued success in the future.

 

Peter Waller

Chair

15 March 2024

 

?Objectives and Key Policies

?The Company's objective is to maximise Total Return and provide investors with a long-term tax free dividend yield whilst maintaining the Company's status as a venture capital trust.

 

Investment Strategy

The Company seeks to build a broad portfolio of investments in early-stage companies focused on growth, with the aim of spreading the maturity profiles and maximising return, as well as ensuring compliance with the VCT Regulations.

The Company predominantly invests in unquoted smaller companies and expects that this will continue to make up the significant majority of the portfolio. It will also retain holdings in cash or near-cash investments to provide a reserve of liquidity which will maximise the Company's flexibility as to the timing of investment acquisitions and disposals, dividend payments and share buy-backs.

Unquoted investments are structured using various investment instruments, including ordinary shares, preference shares, convertible securities and very occasionally loan stock, to achieve an appropriate balance of income and capital growth, having regard to the VCT Regulations. The portfolio is diversified by investing in a broad range of industry sectors. The normal investment period into the portfolio companies is expected to be typically between the range of five to seven years.

Investment Policy

The investment policy of the Company is to invest in UK businesses across a broad range of sectors that blends a mix of businesses operating in established and emerging industries that offer opportunities in the application and development of innovation in their products and services.

These investments will all meet the definition of a Qualifying Investment and be primarily in unquoted UK companies. It is anticipated that the majority of these will be re-investing their profits for growth and the investments will comprise mainly equity instruments.

The Company seeks to build a broad portfolio of investments in early-stage companies focused on growth with the aim of spreading the maturity profiles and maximising return as well as ensuring compliance with the VCT guidelines.

Borrowing

The Company does not borrow and has no borrowing facilities, choosing to fund investments from its own resources.

 

Co-investment

British Smaller Companies VCT2 plc and British Smaller Companies VCT plc (together "the VCTs") typically co-invest in investments, allocating such investments 40 per cent to the Company and 60 per cent to British Smaller Companies VCT plc. However, the Board of the Company has discretion as to whether or not to take up its allocation; where British Smaller Companies VCT plc does not take its allocation, the Board may opt to increase the Company's allocation in such opportunities.

 

The VCTs may invest alongside co-investment funds managed by YFM, the Manager of the VCTs. The VCTs have first priority on all equity investment opportunities meeting the VCT qualifying criteria. Non-VCT qualifying investments are allocated to YFM's co-investment funds.

 

Asset Mix

Cash which is pending investment in VCT-qualifying securities is held in interest bearing instant access, short-notice bank accounts and money market funds.

 

Remuneration Policy

The Company's policy on the remuneration of its directors, all of whom are non-executive, can be found on page 49 of the annual report.

 

Other Key Policies

Details of the Company's policies on the payment of dividends, the DRIS and the buy-back of shares are given on page 1 of the annual report. In addition to these the Company's anti-bribery and environmental and social responsibilities policies can be found below.

?

?Processes and Operations

 

?The Manager is responsible for the sourcing and screening of investment opportunities, carrying out suitable due diligence investigations and making submissions to the Board regarding potential investments.

 

Post investment, the Manager works intensively with the businesses and management teams in which the Company is invested, monitoring progress, effecting change and, where applicable, redefining strategies with a view to maximising values through structured exit processes.

 

The Board regularly monitors the performance of the portfolio and the investment requirements set by the relevant VCT legislation. Reports are received from the Manager regarding the trading and financial position of each investee company and senior members of the Manager regularly attend the Company's Board meetings. Monitoring reports on compliance with VCT regulations are also received at each Board meeting so that the Board can monitor that the Venture Capital Trust status of the Company is maintained and take corrective action if appropriate. Monitoring reports carrying out an independent review of this compliance are received twice a year.

 

The Board reviews the terms of YFM Private Equity Limited's appointment as Manager on a regular basis.

 

YFM Private Equity Limited has performed investment advisory, management, administrative and secretarial services for the Company since its inception on 28 November 2000. The principal terms of the agreement under which these services are performed are set out in note 3.

 

In the opinion of the directors, the continuing appointment of YFM Private Equity Limited as Manager is in the interests of the shareholders as a whole, in view of its experience in managing venture capital trusts and in making, managing and exiting investments of the nature falling within the Company's investment policies.

 

?Key Performance Indicators

 

?Total Return, calculated by reference to the cumulative dividends paid plus net asset value (excluding tax reliefs received by shareholders), is the primary measure of performance in the VCT industry.

 

?The chart on page 12 of the annual report shows how the Total Return of the Company has developed over the last ten years.

 

The evaluation of comparative success of the Company's Total Return is by way of reference to the Share Price Total Return for an index of generalist VCTs that are members of the AIC (based on figures provided by Morningstar). This is the Company's stated benchmark index. A comparison and explanation of the calculation of this return is shown in the Directors' Remuneration Report on page 51 of the annual report.

 

The chart on page 12 of the annual report illustrates the Total Return (excluding tax reliefs received by shareholders) for investors who subscribed to the first fundraising in 2000/01 who have re-invested their dividends.

 

?Shareholder Returns

The Board considers Total Return to be the primary measure of shareholder value. The IRR returns from the offers over the last ten years are set out on page 13 of the annual report. IRR is the annual rate of return that equates the cost at the date of the original investment, with the value of subsequent dividends plus the audited 31 December 2023 net asset value. This excludes the benefit of any initial tax relief.

 

?Set out on page 13 of the annual report is the annualised return over 10, 5, 3, 2 and 1 years to 31 December 2023. The annualised return is calculated with reference to the cumulative dividends paid in the period plus the audited net asset value at 31 December 2023, compared to the net asset value at the beginning of the relevant period.

 

?Expenses

Ongoing Charges

The Ongoing Charges figure, as calculated in line with the AIC recommended methodology, is used by the Board to monitor expenses. This figure shows shareholders the costs of the Company's recurring operational expenses, expressed as a percentage of the average net asset value. Whilst based on historical information, this provides an indication of the likely level of costs that will be incurred in managing the Company in the future.

 

 

Year to

31 December

2023

(%)

Year to

31 December

2022

(%)

Ongoing Charges figure*

2.14

2.08

 

* Alternative Performance Measure

 

Shareholders also benefit from the Company's agreement with the Manager to pay a lower level of management fee of 1 per cent on surplus cash. The Company's ongoing charges ratio is one of the lowest in the VCT industry.

 

Expenses Cap

The total costs incurred by the Company in the year (excluding any performance related fees, trail commission payable to financial intermediaries and VAT) is capped at 2.9 per cent of the total net asset value as at the relevant year end. The treatment of costs in excess of the cap is described in note 3. There was no breach of the expenses cap in the current or prior year.

 

Compliance with VCT Legislative Tests

A principal risk facing the Company is the retention of its VCT qualifying status. The Board receives regular reports on compliance with the VCT legislative tests from the Manager. In addition, the Board receives formal reports from its VCT Tax Adviser (Philip Hare & Associates LLP) twice a year. The Board confirms that during the period, all VCT legislative tests have been met.

 

Under Chapter 3 Part 6 of the Income Tax Act 2007, in addition to the requirement for a VCT's ordinary share capital to be listed in the Official List on a European regulated market throughout the period, there are further specific tests that VCTs must meet following the initial three year provisional period.

 

Income Test

The Company's income in the period must be derived wholly or mainly (70 per cent) from shares or securities.

 

Retained Income Test

The Company must not retain more than 15 per cent of its income from shares and securities.

 

Qualifying Investments Test

At least 80 per cent by value of the Company's investments must be represented throughout the period by shares or securities comprised in Qualifying Investments of investee companies.

 

For shares issued in accounting periods beginning on or after 6 April 2018, at least 30 per cent of those share issues must be invested in Qualifying Investments of investee companies by the anniversary of the accounting period in which those shares are issued.

 

Eligible Shares Test

At least 70 per cent of the Company's Qualifying Investments must be represented throughout the period by holdings of non-preferential shares.

 

Investments made before 6 April 2018 from funds raised before 6 April 2011 are excluded from this requirement.

 

At least 10 per cent of the Company's total investment in each Qualifying Investment must be in eligible shares.

 

In addition, monies are not permitted to be used to finance buy-outs or otherwise to acquire existing businesses or shares.

 

Investment Limits

There is an annual limit for each investee company which provides that they may not raise more than £5 million of state aided investment (including from VCTs) in the 12 months ending on the date of each investment (£10 million for Knowledge Intensive Companies).

 

There is also a lifetime limit that a business may not raise more than £12 million of state aided investment (including from VCTs); the limit for Knowledge Intensive Companies is £20 million.

 

Maximum Single Investment Test

The value of any one investment must not, at any time in the period, represent more than 15 per cent of the Company's total investment value. This is calculated at the time of investment and updated should there be further additions; as such, it cannot be breached passively.

 

The Board can confirm that during the period, all of the VCT legislative tests set out above have been met, where required.

 

Further restrictions placed on VCTs are:

 

Dividends from Cancelled Share Premium

The Finance Act 2014 introduced a restriction with respect to the use of monies in respect of VCTs. In particular, no dividends can be paid out of cancelled share premium arising from shares allotted on or after 6 April 2014 until at least three full financial years have elapsed from the date of allotment.

 

In March 2022 the Company cancelled the balance of its Share Premium, £44.3 million, of which £16.7 million is now distributable. The remaining £27.6 million will become distributable over the period to 1 January 2026, as set out under the Statement of Changes in Equity.

 

Other

No more than seven years can have elapsed since the first commercial sale achieved by the business (ten years in the case of a Knowledge Intensive Company), unless:

a. The business has previously received an investment from a source that has received state aid; or

b. The investment comprises more than 50 per cent of the average of the previous five years' turnover and the funds are to be used in the business to fund growth into new product markets and/or new geographies.

 

Wherever possible, the Company self-assures that an investment is a Qualifying Investment, subject to the receipt of professional advice.

 

?Portfolio Structure and Analysis

 

?Portfolio Structure

The broad range of the portfolio is illustrated on page 16 of the annual report, with 41 per cent of the portfolio valuation being held for more than five years, whilst 97 per cent is held at cost or above. 8 per cent of the portfolio value is held in loans and preference shares, although loans now account for only 3 per cent of the portfolio value.

 

Portfolio Analysis

Also included on page 17 of the annual report is a profile of the portfolio by industry sector.

 

??Investment Review

 

?The movements in the investment portfolio are set out in Table A below:

 

Table A

Investment Portfolio

 

Portfolio

 

Listed

investment

funds

 

Investment

portfolio

 

 

£million

£million

£million

Opening fair value at 1 January 2023

81.4

1.6

83.0

Additions

10.0

0.7

10.7

Disposal proceeds

(4.1)

(2.2)

(6.3)

Valuation movement

9.1

(0.1)

9.0

Closing fair value at 31 December 2023

96.4

-

96.4

Accrued income

1.3

-

1.3

Financial assets - investments

97.7

-

97.7

 

At 31 December 2023 the investment portfolio was valued at £96.4 million, representing 71.1 per cent of net assets (74.2 per cent at 31 December 2022). Cash, cash equivalents and current asset investments at 31 December 2023 of £39.1 million represent 28.8 per cent of net assets (25.5 per cent at 31 December 2022).

 

The Portfolio

 

£96.4 million

Fair value of the portfolio 

(2022: £81.4 million)

26

Number of portfolio companies with a value of more than £0.75 million

(2022: 25)

£0.7 million

Income from the portfolio

(2022: £0.8 million)

£10.0 million

Level of investment in the year

(2022: £16.3 million)

£9.1 million

Return from the portfolio in the year

(2022: £8.0 million)

 

The portfolio showed robust performance in the period, adding £9.1 million of value on the opening fair value of £81.4 million. The composition of investments continues to show its dynamism, with £10.0 million invested in the period and cash proceeds of £4.1 million received.

 

Fair value changes

Table B

Investment Portfolio

£million

%

Gain in fair value from the portfolio

8.0

88

Gain on disposal over opening value from the portfolio

1.1

12

Gain arising from the portfolio

9.1

100

Fall in value of listed investment funds/deferred income recognised

-

Gain arising from the investment portfolio

9.1

 

 

Of the £9.1 million gain in the year, £1.1 million arose from investments which were realised, including MacroArt (£0.6 million) and E2E (£0.5 million). Further details can be found in the Chair's Statement and note 7.

 

The ongoing portfolio delivered a net value gain of £8.0 million in the year. It is pleasing to see the fair value increases arising across a range of companies, including tech-focused businesses such as Unbiased, Traveltek, SharpCloud, Vypr and AutomatePro, as well as legacy companies such as KeTech and Displayplan.

 

Some decreases in value have been seen, as in Relative Insight and Sipsynergy; but the Manager continues to work closely with the companies' management teams to navigate their current challenges.

 

Other Significant Investment Movements

Investments

During the year ended 31 December 2023, the Company invested £10.0 million across nine companies.

 

Four new companies were added to the portfolio, receiving aggregate investment of £6.9 million; while a further £3.1 million was invested across five existing portfolio companies. The analysis of these investments is shown in Table C. The case study on page 24 of the annual report gives more information on the investment in GEEIQ.

 

Table C

Investments

Company

Investments made

New

£million

Follow-on

£million

Total

£million

DrDoctor

2.4

-

2.4

Workbuzz

1.7

-

1.7

Quality Clouds

-

1.6

1.6

GEEIQ

1.6

-

1.6

Xapien

1.2

-

1.2

Relative Insight

-

0.5

0.5

Force24

-

0.5

0.5

Vuealta

-

0.3

0.3

Elucidat

-

0.2

0.2

Portfolio

6.9

3.1

10.0

Listed investment funds

0.7

Total additions in the year

10.7

 

Disposal of Investments

During the year to 31 December 2023, the Company received proceeds from disposals of £6.3 million (£4.1 million from the portfolio), a net gain of £1.0 million over the opening carrying value at the beginning of the year, and an overall net gain of £0.6 million over cost. This included the successful realisations of E2E and MacroArt, as well as the small listed investment funds portfolio (see below). Further details are given in the Chair's statement above.

 

Table D

Disposal of Investments

Net

proceeds

from sale

of investments

£million

Opening

value

31 December

2022

£million

Gain (loss) on

opening value

£million

Portfolio

4.1

3.0

1.1

Listed investment funds*

2.2

2.3

(0.1)

Total investment disposals

6.3

5.3

1.0

* opening value includes additions made during the year.

 

Further analysis of all investments sold in the year can be found in note 7.

 

Investment Portfolio Composition

As at 31 December 2023, the portfolio was valued at £96.4 million, comprising wholly of unquoted investments. An analysis of the movements in the year is shown on in note 7.

 

The portfolio has 26 investments valued above £0.75 million, one more than a year earlier, with the single largest investment, Matillion, representing 16.5 per cent of the net asset value.

 

The charts on pages 16 and 17 of the annual report show the diversity of the portfolio, split by industry sector, age of investment, investment instrument and the valuation compared to cost.

 

Under VCT legislation, it is not possible to deposit funds for longer than seven days, which means that cash deposits must be available on very short notice. Given the current environment of high interest rates the Company is taking an active approach to cash management, whilst pursuing its primary aim of capital preservation. This is effected through the use of a pool of money market funds (which can be converted back to cash with immediate notice) and cash deposits held with tier one banking institutions. £1.3 million of income was earned from money market funds and bank deposits during the year. At 31 December 2023, the Company was achieving a weighted average return on liquid assets of 4.5 per cent.

 

During the year, the Company realised its small diversified quoted portfolio of listed investment funds, managed by Brewin Dolphin, held as part of its previous treasury operations. This sale generated proceeds of £2.2 million.

 

Valuation Policy

Unquoted investments are valued in accordance with both IFRS 13 'Fair Value Measurement' and International Private Equity and Venture Capital Guidelines, December 2022 edition (the "IPEV Guidelines").

 

Initially, at the first quarter-end following investment, investments are valued at the price of the funding round; following this, the valuation switches to a new primary basis for all subsequent periods.

 

The valuation methodology applied depends upon the facts and circumstances of each individual investment. This may be with reference to revenue multiples, earnings multiples, net assets, discounted cash flows or calibrated from the price of the most recent investment.

 

The full valuation policy is set out in note 1.

 

Table E shows the value of investments within each valuation category as at 31 December 2023.

 

With continued investment in earlier stage businesses that are investing for growth, the majority of valuations continue to be based on revenue multiples.

 

Table E

Valuation Policy

 

2023

2022

Valuation

£million

% of

portfolio

by value

% of

portfolio

by value

Revenue multiple

80.9

84

75

Earnings multiple

6.4

7

12

Sale proceeds

6.4

7

3

Cost or price of recent investment, reviewed for change in fair value

0.3

-

7

Net assets, reviewed for change in fair value

2.4

2

3

Total

96.4

100

100

 

Sustainable Investment and Environmental, Social and Governance ("ESG") Management

The Company backs small UK businesses to help them to grow and produce strong financial returns for shareholders with the additional aim of building better businesses that are ultimately more sustainable.

 

In order to deliver more sustainable businesses, and to meet its commitments under the Principles for Responsible Investment (PRI), the Manager has continued to develop its processes in this area.

 

The Manager's approach is based on the belief that good businesses:

 

? Grow our economy

? Improve our society

? Value their people

? Protect the environment

 

?These aims are consistent with the Company's financial aims because businesses which improve in these areas also strengthen their resilience and value creation potential through their increased attractiveness to customers, employees, suppliers and eventual future owners and investors.

 

Sustainable Investment Principles

This set of principles guides the Manager's investment process:

? To seek to understand the ESG related impacts and potential impacts on portfolio companies, aiming to grow and enhance positive outcomes and to avoid, reduce or minimise any negative impacts over an investment's lifetime, leaving them overall better businesses;

? To play a positive role in the investor, business and wider communities by promoting good practice in ESG management, and by being transparent in the way that investments are made and how the Manager behaves;

? To increase focus on the challenge of climate change both as it may be affected by our investments, and as it may impact on them and their resilience to possible climate change scenarios;

? To show leadership by managing the Manager's own business' ESG impacts to the best of their ability; and

? To be a proactive signatory to the PRI and to integrate its principles into the Manager's business practices.

In line with the PRI the Manager has developed processes to help the portfolio businesses to be better in each of these spheres, by assessing them in terms of creating positive impacts and outcomes and preventing or minimising negative ones.

 

The Manager has more recently developed and integrated its ESG management processes, which are:

 

Pre-investment Phase:

Structured processes at the pre-investment stage to identify areas of potential ESG improvement as part of the due diligence and pre-investment deliberations. Appropriate data is collected and assessed on each business against ESG criteria at the point of investment as a benchmark against which to evaluate future progress.

 

Portfolio Phase:

For those investments made since 2020, based on the data collected at the point of investment at the start of the portfolio phase, bespoke areas for improvement are agreed with each management team together with consequent objectives and targets. A similar process has been applied to the significant majority of investments made prior to 2020. Improvements are then measured and recorded against a set of ESG criteria using the Manager's bespoke ESG framework, refreshing targets annually and placing focus on any new issues as they become more material in the management of the company and in meeting the expectations of its stakeholders.

 

Reporting:

Annual reports will be produced, using the Manager's ESG framework for consistency, recording the relevant initiatives, impacts and ESG KPI performance of each company and providing an overview of progress across the Manager's portfolios.

Note that Investment Companies are not within scope for reporting under the Task Force on Climate-Related Financial Disclosures (TCFD); and the Company does not use more than 40,000kWh of energy and therefore is not required to report on its energy usage within Streamlined Energy and Carbon Reporting regulations.

 

ESG Performance Data and Reporting

ESG KPI data analysis

The Manager has developed its ESG KPI data collation process. It has established a data set reflecting the above ESG themes and a means of collecting this to make year on year comparisons for each company and across the portfolio. Where possible baseline data has been collected from the date of investment with a view to showing where the Manager's support has made a difference during the hold period to the reporting date.

Annual company specific ESG performance progress report

The reviews that the Manager has been conducting enabled the identification of relative strengths and weaknesses and agreement of programmes of action with each business.

Since 2021 the Manager has moved to recording annual updates and agreed actions in a more visual and detailed report on both qualitative and quantitative aspects of each company's progress. As well as using this for portfolio reporting to investors it will be used as an engagement tool with the senior management teams of each company.

 

2023 ESG KPI Report for Investments held in YFM's VCT funds

 

?Growing our economy

? ?£74 million of R&D investment during 2023

? £115 million of export sales achieved in 2023

?Improving our society

? ?95 per cent of companies were independently chaired in 2023

? 45 per cent of companies had female directors on boards, with 15 per cent having a female CEO/MD

? 65 per cent of businesses had a designated board member with responsibility for improving ESG issues

?Valuing our people

? ?35 per cent of the portfolio workforce was female in 2023

? 750 new jobs were created from date of investment to 2023 representing a 50 per cent increase

? 60 per cent had mental wellbeing programmes in place and 80 per cent held regular employee engagement surveys

? 43,000 hours of non-statutory training was given to employees

?Protecting our environment

? 20 per cent formally measure their carbon footprint

? 10 per cent offset all or a defined portion of their carbon impact

? 15 per cent formally set a target date and strategy for achieving net zero carbon emissions

Summary and Outlook

The portfolio continues to deliver good underlying revenue growth, while also demonstrating good levels of capital efficiency over the past 12 months. Portfolio companies continue to navigate difficult macroeconomic conditions well, with the portfolio well placed to benefit from a hoped for improvement in the economic environment in 2024.

We continue to see a good pipeline of potential investments in a range of growth companies, as well as opportunities to further support the continued growth of the current portfolio. We thank investors for their continuing support in the Company's 2023/24 fundraising, and are looking forward to putting the funds raised to work.

 

Eamon Nolan

YFM Private Equity Limited

15 March 2024

 

?Portfolio Summary at 31 December 2023

 

Name of

company

Date of

initial

investment

Location

Industry

Sector

Amount

invested

 

Valuation at

31 December

2023

 

Recognised

income/

proceeds

to date

 

Realised &

unrealised

 value to date*

 

£000

£000

£000

£000

Matillion Limited

Nov-16

Manchester

Data

1,778

22,334

5,946

28,280

Unbiased EC1 Limited

Dec-19

London

Tech-enabled Services

3,731

8,365

-

8,365

Outpost VFX Limited

Feb-21

Bournemouth

New Media

3,000

5,879

30

5,909

Displayplan Holdings Limited

Jan-12

Stevenage

Business Services

700

4,741

1,890

6,631

Elucidat Ltd

May-19

Brighton

Application Software

2,840

4,398

181

4,579

Force24 Ltd

Nov-20

Leeds

Application Software

2,600

4,126

12

4,138

Wooshii Limited

May-19

London

New Media

3,096

3,638

423

4,061

SharpCloud Software Limited

Oct-19

London

Data

2,271

3,309

-

3,309

Vypr Validation Technologies Limited

Jan-21

Manchester

Tech-enabled Services

2,200

3,222

-

3,222

ACC Aviation Group Limited

Nov-14

Reigate

Business Services

1,379

2,905

3,525

6,430

KeTech Holdings Limited/KeTech Technology Holdings Limited

Nov-15

Nottingham

Tech-enabled Services

2,000

2,765

2,599

5,364

Quality Clouds Limited

May-22

London

Cloud & DevOps

2,610

2,763

-

2,763

Traveltek Group Holdings Limited

Oct-16

East Kilbride

Application Software

1,163

2,731

626

3,357

Investment companies

Apr-15

-

-

2,500

2,443

71

2,514

DrDoctor (via ICNH Ltd)

Feb-23

London

Application Software

2,377

2,377

-

2,377

Workbuzz Analytics Limited

Jun-23

Milton Keynes

Application Software

1,718

2,111

-

2,111

AutomatePro Limited

Dec-22

London

Cloud & DevOps

1,483

2,088

-

2,088

Tonkotsu Limited

Jun-19

London

Retail & Brands

1,592

2,020

-

2,020

GEEIQ (via Checkpoint GG Limited)

Sep-23

London

Data

1,572

1,821

-

1,821

Vuealta Holdings Limited

Sep-21

London

Tech-enabled Services

2,386

1,660

3,070

4,730

Summize Limited

Oct-22

Manchester

Application Software

1,200

1,604

-

1,604

Frescobol Carioca Ltd

Mar-19

London

Retail & Brands

1,200

1,518

-

1,518

Plandek Limited

Oct-22

London

Cloud & DevOps

1,380

1,380

-

1,380

Relative Insight Limited

Mar-22

Lancaster

Tech-enabled Services

2,536

1,357

-

1,357

Xapien (via Digital Insight Technologies Limited)

Mar-23

London

Application Software

1,160

1,294

-

1,294

Biorelate Limited

Nov-22

Manchester

Application Software

1,040

1,146

-

1,146

Panintelligence (via Paninsight Limited)

Nov-19

Leeds

Data

1,000

1,046

-

1,046

Sipsynergy (via Hosted Network Services Limited)

Jun-16

Hampshire

Cloud & DevOps

2,045

715

1

716

Other investments below £0.5 million

9,296

671

4,506

5,177

Total unquoted investments

63,853

96,427

22,880

119,307

Full disposals to date

49,585

-

79,845

79,845

Total portfolio 

113,438

96,427

102,725

199,152

 

*represents recognised income and proceeds received to date plus the unrealised valuation at 31 December 2023.

 

?Summary of Portfolio Movement since 31 December 2022

 

?

Name of Company

Investment

valuation at

31 December

2022

 

Disposal

proceeds

 

Additions

 

Valuation

gains including

profits/(losses)

on disposal

 

Investment

valuation at

31 December

2023

 

£000

£000

£000

£000

£000

Unbiased EC1 Limited

6,072

-

-

2,293

8,365

Traveltek Group Holdings Limited

1,359

-

-

1,372

2,731

KeTech Holdings Limited/ KeTech Technology Holdings Limited

1,788

-

-

977

2,765

SharpCloud Software Limited

2,508

-

-

801

3,309

Displayplan Holdings Limited

4,109

-

-

632

4,741

Vypr Validation Technologies Limited

2,598

-

-

624

3,222

AutomatePro Limited

1,483

-

-

605

2,088

Macro Art Holdings Limited

409

(990)

-

581

-

Force24 Ltd

3,091

-

500

535

4,126

Tonkotsu Limited

1,485

-

-

535

2,020

E2E Engineering Limited

800

(1,305)

-

505

-

Matillion Limited

21,874

-

-

460

22,334

Summize Limited

1,200

-

-

404

1,604

Workbuzz Analytics Limited

-

-

1,718

393

2,111

GEEIQ (via Checkpoint GG Limited)

-

-

1,572

249

1,821

Frescobol Carioca Ltd

1,284

-

-

234

1,518

Elucidat Ltd

4,039

-

200

159

4,398

Quality Clouds Limited

1,000

-

1,611

152

2,763

Xapien (via Digital Insight Technologies Limited)

-

-

1,160

134

1,294

Vuealta Holdings Limited/Vuealta Group Limited

1,192

-

357

111

1,660

Biorelate Limited

1,040

-

-

106

1,146

Wakefield Acoustics (via Malvar Engineering)

648

(712)

-

64

-

Panintelligence (via Paninsight Limited)

1,000

-

-

46

1,046

DrDoctor (via ICNH Ltd)

-

-

2,377

-

2,377

Plandek Limited

1,380

-

-

-

1,380

Ncam Technologies Limited

1,175

(1,118)

-

(57)

-

Outpost VFX Limited

6,202

-

-

(323)

5,879

Wooshii Limited

4,197

-

-

(559)

3,638

Sipsynergy (via Hosted Network Services Limited)

1,378

-

-

(663)

715

ACC Aviation Group Limited

3,575

-

-

(670)

2,905

Relative Insight Limited

2,010

-

536

(1,189)

1,357

Other investments £0.5 million and below

2,489

-

-

625

3,114

Total investments

81,385

(4,125)

10,031

9,136

96,427

Accrued income

1,275

Financial assets - investments

 

 

 

 

97,702

?Risk Factors

?The Board carries out a regular review of the risk environment in which the Company operates. The emerging and principal risks and uncertainties identified by the Board and techniques used to mitigate these risks are set out in this section.

 

The Board seeks to mitigate its emerging and principal risks by setting policy, regularly reviewing performance and monitoring progress and compliance. In the mitigation and management of these risks, the Board rigorously applies the principles detailed in section 8: "Audit, Risk and Internal Control" of the AIC Code. Details of the Company's internal controls are contained in the Corporate Governance Internal Control section on pages 47 and 48 of the annual report and further information on exposure to risks, including those associated with financial instruments, can be found in note 17a of the financial statements.

 

The Board carries out a regular review of the risk environment in which the Company operates, together with changes to the operational environment and idiosyncratic risks. The Board also identifies emerging risk which impact on the Company. In the period the most notable emerging risks have been:

 

? Global trade: on-going global trade tensions between major economies have the potential to disrupt global supply chains which could cause a slowdown in economic activity.

? Geopolitical instability: geopolitical tensions, such as the conflicts in the Middle East and Eastern Europe can create uncertainty, disrupt global markets and create market volatility.

? Rising interest rates: whilst interest rates appear to be stabilising, higher interest rates can increase borrowing costs for businesses and consumers, potentially leading to reduced spending and investment, and ultimately economic growth.

 

The principal risks the Company faces are considered in more detail below.

 

VCT Qualifying Status:

Risk - A failure to continue to meet the VCT qualifying criteria could result in the loss of approved VCT status. The loss of such approval could lead to investors losing the various tax benefits associated with VCT investments.

Mitigation - The Manager tracks the Company's VCT qualifying status on an ongoing and continual basis. Furthermore, external independent experts have been retained and report on the VCT qualifying status regularly throughout the year.

 

The Manager reports to the Board on a quarterly basis.

 

Further information on these requirements can be found under the heading "Compliance with VCT Legislative Tests" above.

 

Change - No overall change in risk exposure.

 

Economic:

Risk - Macroeconomic events such as geopolitical developments, external shocks and economic recession could adversely affect smaller companies' valuations, as they may be more vulnerable to changes in trading conditions or the sectors in which they operate. This could lead to a reduction in the Company's share price, resulting in capital losses for Shareholders.

Mitigation - The Board, in conjunction with the Manager, regularly assesses the resilience of the portfolio. The Company has a clear Investment Policy (summarised above) and invests in a diverse portfolio of companies across a range of sectors, which helps to mitigate against the impact on any one sector. The Manager also maintains adequate liquidity to make sure it can provide follow-on investment to those portfolio companies which require it and which is supported by the individual investment case.

Change - Up. Continued uncertainty in an environment that currently includes high inflation, high interest rates and other economic factors.

 

Investment Performance:

Risk - The Company invests in small and medium-sized VCT qualifying companies, which, by their nature, entail a higher level of risk and shorter cash runway than investments in larger quoted companies. Poor performance could reduce returns for shareholders through downward valuations.

Mitigation - The Board places reliance on the Manager's significant experience, expertise and strong track record of investing in early-stage unquoted companies. The Manager has a rigorous and robust formal process in selecting new companies which includes appropriate due diligence and approval by an Investment Committee made up of the senior members of the Manager's investment team.

Change - No overall change in risk exposure.

 

Strategy:

Risk - The Board fails to set appropriate strategic objectives and fails to monitor the Company's implementation of the strategy, which leads to poor performance.

Poor performance leads to a lack of investor demand for the Company's shares resulting in difficulty raising new capital and lack of cash available to fund corporate activity.

Mitigation - The Board reviews strategy annually. At each of the Board meetings, the directors review the appropriateness of the Company's objectives and stated strategy in response to changes in the operating environment and peer group activity. It also reviews compliance of the Manager with the stated investment strategy.

Change - Up. Small increase due to the difficult macro environment and more challenging trading conditions for some portfolio companies.

 

Legislative & Regulatory:

Risk - The Company fails to comply with applicable laws and regulations including VCT Rules, UK Listing Authority Rules, AIC Code on Corporate Governance, Stewardship Code, Companies Act, Bribery Act, Market Abuse Regulations, data protection rules, Criminal Finances Act and relevant Taxes Acts and as a result loses its approval as a VCT.

Changes to the UK legislation, in particular relating to the VCT Rules, could have an adverse effect on the Company's ability to achieve satisfactory investment returns.

Mitigation - The Manager ensures that it has suitably qualified members of staff who are experienced with regulatory requirements and relevant accounting standards. The Manager and the Company Secretary have procedures in place to ensure recurring Listing Rules requirements are met.

The Board and Manager review corporate governance, regulatory legislative change and political developments on a continual basis and seek additional advice as and when required.

The Manager is a member of the Venture Capital Trust Association which engages with the Government to help shape future legislation.

Change - Down. A reduction in this risk, as result of the ten year extension of the VCT legislation sunset clause to 6 April 2035, continuing shareholders' rights to income tax relief on newly issued shares.

 

Operational:

Risk - Key service providers, such as the Manager, have inadequate procedures for the identification, evaluation and management of risks, cyber security and data protection putting the Company's assets and data at risk.

Mitigation - The Board regularly reviews the system of internal controls, both financial and non-financial operated by the Company and the Manager. These include controls designed to ensure that the Company's assets are safeguarded and proper accounting records are maintained.

Change - No overall change in risk exposure.

 

Cyber Security and Information Technology:

Risk - A failure in IT systems and controls might lead to business interruption, loss of data, the inability of the Manager to provide accurate reporting and monitoring or the loss of Company records.

Mitigation - The Manager has in place significant cybersecurity controls, including multifactor authentication, email protection software, monitored firewalls and regularly updated electronic devices. Staff at the Manager regularly receive training in relation to their cybersecurity obligations. The Manager is Cyber Essentials Plus certified.

Due diligence is conducted on other service providers, including a review on their controls for information security.

Change - No overall change on balance, although cyber threat remains a significant risk area faced by all service providers, with ever increasing sophistication of attacks.

 

Liquidity:

Risk -

a. The Company may not have sufficient liquidity available to meet its financial obligations.

b. The VCT invests in smaller unquoted companies, which by their nature are illiquid, therefore they may be difficult to realise, at fair market value, at short notice

Mitigation - The Company's overall liquidity risks and cashflow forecasts are monitored on an ongoing basis by the Manager and on a quarterly basis by the Board.

The Company's valuation methodology takes account of potential liquidity restrictions in the markets in which it invests.

For any publicly listed investments, accounting standards require an ongoing assessment of the liquidity of the stock.

The Manager regularly reviews its exit plans for investee companies to allow it to identify the optimal point at which to seek a sale. As part of a planned exit, the assistance of a third party adviser will normally be sought, with a view to identifying the largest number of possible purchasers.

Change - Up. A small increase to reflect the potential impacts of economic uncertainty, including the impacts on fundraising and ability to exit investments.

?Other Matters

 

?Section 172 Statement

This Section 172 Statement should be read in conjunction with the other contents of the Strategic Report, on pages 6 to 36 of the annual report.

 

Section 172 of the Companies Act 2006 requires that a director must act in the way that they consider, in good faith, would be most likely to promote the success of the company for the benefit of its members as a whole, and in doing so have regard (amongst other matters) to:

 

? The likely consequences of any decision in the long term;

? The interests of the company's employees;

? The need to foster the company's business relationships with suppliers, customers and others;

? The impact of the company's operations on the community and the environment;

? The desirability of the company maintaining a reputation for high standards of business conduct; and

? The need to act fairly as between members of the company.

The Company takes a number of steps to understand the views of investors and other key stakeholders and considers these, along with the matters set out above, in Board discussions and decision making.

 

Key Stakeholders

As an investment company with no employees, the Company's key stakeholders are its investors, its service providers and its portfolio companies.

 

Investors

The Board engages and communicates with shareholders in a variety of ways.

 

The Company encourages shareholders to attend its Annual General Meeting.

 

Along with British Smaller Companies VCT plc, the Company held two Investor Workshops during the year. An in-person workshop was held on 20 June 2023 and an online webinar was hosted on 27 November 2023. Both were well attended.

 

Maintaining the Company's status as a VCT is critical to meeting the Company's objective to maximise Total Return and provide investors with an attractive long-term tax-free dividend yield. The Company receives regular reports on this issue from the Manager and has taken various steps in the year to ensure that the relevant tests are met.

 

The Board also aims for investors to continue to have tax efficient opportunities to invest in the Company, and to generate tax-free returns from both capital appreciation and ongoing dividends.

 

After carefully considering its funding needs, on 20 September 2023 the Company issued a prospectus, alongside British Smaller Companies VCT plc, to raise up to £90 million in aggregate for the 2023/24 tax year.

 

During the year the Board kept its arrangements for dividends, share buy-backs and the dividend re-investment scheme under constant review. Along with normal dividends totalling 3.0 pence per ordinary share in the year ended 31 December 2023, a special dividend of 2.25 pence per ordinary share was paid in January 2023, following the realisation of the Company's investments in Springboard and Intelligent Office in 2022.

 

Manager

The Company's most important service provider is its Manager. There is regular contact with the Manager, and members of the Manager's board attend all of the Company's Board meetings. There is also an annual strategy meeting with the Manager, alongside the board of British Smaller Companies VCT plc.

 

The Manager maintains strong relationships with relevant media publications and a wide range of distributors for the Company's shares, including wealth managers, independent financial advisers and execution-only brokers. RAM Capital acts as a promoter of the Company's shares to smaller distributors.

 

The Company is a member of the Association of Investment Companies which promotes the interests of investment companies, including VCTs. The Manager is a founder member of the Venture Capital Trust Association, which promotes the interests of VCTs in a variety of ways.

 

Portfolio Companies

The Company holds minority investments in its portfolio companies and has delegated the management of the portfolio to the Manager. The Manager provides the Board with regular updates on the performance of each portfolio company at least quarterly and the Board is made aware of all major issues.

 

The Manager has a dedicated Portfolio team to assist the portfolio companies with the challenges that they face as fast-growing companies. The Manager promotes ongoing sustainable growth within the businesses; this often involves improving systems and processes, as well as significant job creation.

 

Employees

The Company has no employees. The Board is composed of one female non-executive director and two male non-executive directors. For a review of the policies used when appointing directors to the Board of the Company, please refer to the Directors' Remuneration Report.

 

Environment and Community

The Company seeks to ensure that its business is conducted in a manner that is responsible to the environment. The management and administration of the Company is undertaken by the Manager, YFM Private Equity Limited, which recognises the importance of its environmental responsibilities and is a signatory of the United Nations' Principles for Responsible Investment.

 

More details of the work that the Manager has achieved in this area are set out above. Its Sustainable Investment Policy can be found at www.yfmep.com/who-we-are/our_impact/.

 

Business Conduct

The Company has a zero tolerance approach to bribery and corruption. The following is a summary of the controls in place:

? The Company conducts all its business in an honest and ethical manner. The Company is committed to acting professionally, fairly and with integrity in all its business dealings and relationships;

? The Company prohibits the offering, the giving, the solicitation or the acceptance of any bribe;

? The Company has communicated its anti-bribery & corruption policy to the Manager and its other service providers; and

? The Manager has its own Anti-Bribery & Corruption Policy and monitors portfolio companies' compliance with their legal obligations.

Peter Waller

Chair

15 March 2024

 

?Statement of Comprehensive Income

For the year ended 31 December 2023

 

Notes

2023

2022

Revenue

£000

Capital

£000

Total

£000

Revenue

£000

Capital

£000

Total

£000

Gains on investments held at fair value

7

-

8,043

8,043

-

4,287

4,287

Gain on disposal of investments

7

-

1,018

1,018

-

3,586

3,586

Gain arising from the investment portfolio

-

9,061

9,061

-

7,873

7,873

Income

2

2,047

-

2,047

1,075

-

1,075

Total income

2,047

9,061

11,108

1,075

7,873

8,948

 

 

 

Administrative expenses:

 

 

 

Manager's fee

(536)

(1,611)

(2,147)

(447)

(1,339)

(1,786)

Incentive fee

-

(1,601)

(1,601)

-

(635)

(635)

Other expenses

(669)

-

(669)

(274)

-

(274)

3

(1,205)

(3,212)

(4,417)

(721)

(1,974)

(2,695)

Profit before taxation

842

5,849

6,691

354

5,899

6,253

Taxation

4

-

-

-

-

-

-

Profit for the year

842

5,849

6,691

354

5,899

6,253

Total comprehensive income for the year

842

5,849

6,691

354

5,899

6,253

Basic and diluted earnings per ordinary share

6

0.39p

2.69p

3.08p

0.20p

3.25p

3.45p

 

The accompanying notes on pages 65 to 89 of the annual report are an integral part of these financial statements.

 

The Total column of this statement represents the Company's Statement of Comprehensive Income, prepared in accordance with UK adopted international accounting standards. The supplementary Revenue and Capital columns are prepared under the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' (issued in July 2022 - "SORP") published by the AIC.

 

?Balance Sheet

At 31 December 2023

 

Notes

2023

£000

2022

£000

ASSETS

 

Non-current assets

 

 

 

Financial assets at fair value through profit or loss

7

97,702

82,981

Accrued income and other assets

210

948

 

 

97,912

83,929

Current assets

 

 

Accrued income and other assets

475

287

Current asset investments

23,500

1,988

Cash at bank

15,571

26,486

39,546

28,761

LIABILITIES

 

 

Current liabilities

 

 

Trade and other payables

(1,842)

(821)

Net current assets

37,704

27,940

Net assets

135,616

111,869

Shareholders' equity

 

Share capital

25,014

20,014

Share premium account

25,386

858

Capital redemption reserve

88

88

Other reserves

2

2

Merger reserve

5,525

5,525

Capital reserve

37,458

52,263

Investment holding gains and losses reserve

40,245

31,762

Revenue reserve

1,898

1,357

Total shareholders' equity

135,616

111,869

Net asset value per ordinary share

8

59.3p

61.6p

 

The accompanying notes on pages 65 to 89 of the annual report are an integral part of these financial statements.

 

The financial statements were approved and authorised for issue by the Board of Directors and were signed on its behalf on 15 March 2024.

 

Peter Waller

Chair

 

?Statement of Changes in Equity

For the year ended 31 December 2023

 

Share

capital

 

Share

premium

account

 

Other

reserves*

 

Capital

reserve

 

Investment

holding gains

and losses

reserve

 

Revenue

reserve

 

Total

equity

 

 

£000

£000

£000

£000

£000

£000

£000

Balance at 31 December 2021

15,808

24,122

5,615

12,818

28,009

1,003

87,375

Revenue return for the year

-

-

-

-

-

354

354

Expenses charged to capital

-

-

-

(1,974)

-

-

(1,974)

Investment holding gain on investments held at fair value

-

-

-

-

4,287

-

4,287

Realisation of investments in the year

-

-

-

3,586

-

-

3,586

Total comprehensive income for the year

-

-

-

1,612

4,287

354

6,253

Issue of share capital

4,023

21,274

-

-

-

-

25,297

Issue of shares - DRIS

183

902

-

-

-

-

1,085

Issue costs **

-

(1,125)

-

-

-

-

(1,125)

Share premium cancellation

-

(44,315)

-

44,315

-

-

-

Purchase of own shares

-

-

-

(1,572)

-

-

(1,572)

Dividends

-

-

-

(5,444)

-

-

(5,444)

Total transactions with owners

4,206

(23,264)

-

37,299

-

-

18,241

Realisation of prior year investment holding gains

-

-

-

534

(534)

-

-

Balance at 31 December 2022

20,014

858

5,615

52,263

31,762

1,357

111,869

Revenue return for the year

-

-

-

-

-

842

842

Expenses charged to capital

-

-

-

(3,212)

-

-

(3,212)

Investment holding gain on investments held at fair value

-

-

-

-

8,043

-

8,043

Realisation of investments in the year

-

-

-

1,018

-

-

1,018

Total comprehensive (expense) income for the year

-

-

(2,194)

8,043

842

6,691

Issue of share capital

4,636

24,077

-

-

-

-

28,713

Issue of shares - DRIS

364

1,719

-

-

-

2,083

Issue costs **

-

(1,268)

-

-

-

-

(1,268)

Purchase of own shares

-

-

-

(1,516)

-

-

(1,516)

Dividends

-

-

-

(10,655)

-

(301)

(10,956)

Total transactions with owners

5,000

24,528

-

(12,171)

-

(301)

17,056

Realisation of prior year investment holding losses

-

-

-

(440)

440

-

-

Balance at 31 December 2023

25,014

25,386

5,615

37,458

40,245

1,898

135,616

The accompanying notes on pages 65 to 89 of the annual report are an integral part of these financial statements.?

Reserves available for distribution

Under the Companies Act 2006 the capital reserve and the revenue reserve are distributable reserves. The table below shows amounts that are available for distribution.

 

Capital

reserve

£000

Revenue

reserve

£000

Total

£000

Distributable reserves as shown above

37,458

1,898

39,356

Income/proceeds not yet distributable

(253)

(1,315)

(1,568)

Revaluation losses

(630)

-

(630)

Cancelled share premium not yet distributable (see below)

(27,580)

-

(27,580)

Reserves available for distribution***

8,995

583

9,578

 

* Other reserves include the capital redemption reserve, the merger reserve and the other reserve, which are non-distributable. The other reserve was created upon the exercise of warrants, the capital redemption reserve was created for the purchase and cancellation of own shares, and the merger reserve was created on the merger with British Smaller Technologies Company VCT plc.

** Issue costs include both fundraising costs and costs incurred from the Company's DRIS.

*** Following the circulation of the Annual Report to shareholders.

 

The merger reserve was created to account for the difference between the nominal and fair value of shares issued as consideration for the acquisition of the assets and liabilities of British Smaller Technology Companies VCT plc. The reserve was created after meeting the criteria under section 131 of the Companies Act 1985 and the provisions of the Companies Act 2006 for merger relief. The merger reserve is a non-distributable reserve.

 

The capital reserve and revenue reserve are both distributable reserves. The reserves total £39,356,000, representing a decrease of £14,264,000 during the year. The directors also take into account the level of the investment holding gains and losses reserve and the future requirements of the Company when determining the level of dividend payments.

 

Of the potentially distributable reserves of £39,356,000 shown above, £1,568,000 relates to income/proceeds not yet distributable and £27,580,000 relates to cancelled share premium which will become distributable from the dates shown in the table below. In addition revaluation losses of £630,000 included within the investment holding gains and losses reserve are not considered to be recoverable.

 

Total share premium cancelled will be available for distribution from the following dates:

 

£000

1 January 2025

7,387

1 January 2026

20,193

Cancelled share premium not yet distributable

27,580

 

?Statement of Cash Flows

For the year ended 31 December 2023

 

Notes

2023

£000

2022

£000

Net cash outflow from operating activities

(1,821)

(5,911)

Cash flows generated from (used in) investing activities

 

Cash maturing from fixed term deposits

1,988

-

Purchase of financial assets at fair value through profit or loss

7

(10,696)

(17,978)

Proceeds from sale of financial assets at fair value through profit or loss

7

6,031

12,929

Deferred consideration

7

27

4

Net cash outflow from investing activities

(2,650)

(5,045)

Cash flows from (used in) financing activities

 

Issue of ordinary shares

28,713

25,297

Costs of ordinary share issues*

(1,268)

(1,125)

Purchase of own ordinary shares

(1,516)

(1,572)

Dividends paid

5

(8,873)

(4,359)

Net cash inflow from financing activities

17,056

18,241

Net increase in cash and cash equivalents

12,585

7,285

Cash and cash equivalents at the beginning of the year

26,486

19,201

Cash and cash equivalents at the end of the year

39,071

26,486

 

* Issue costs include both fundraising costs and expenses incurred from the Company's DRIS

Cash and cash equivalents comprise:

Money market funds

23,500

-

Cash at bank

15,571

26,486

Cash and cash equivalents at the end of the year

39,071

26,486

 

Reconciliation of Profit before Taxation to Net Cash Outflow from Operating Activities

 

2023

£000

2022

£000

Profit before taxation

6,691

6,253

Increase (decrease) in trade and other payables

1,021

(3,722)

Increase in accrued income and other assets*

(472)

(529)

Gain on disposal of investments

(1,018)

(3,586)

Gains on investments held at fair value

(8,043)

(4,287)

Capitalised income

-

(40)

Net cash outflow from operating activities

(1,821)

(5,911)

* Includes accrued income and other assets disclosed in Note 7 - Financial Assets at Fair Value through Profit or Loss - Investments.

 

The accompanying notes on pages 65 to 89 of the annual report are an integral part of these financial statements.

Notes to the Financial Statements

 

1. Principal Accounting Policies

 

Basis of Preparation

The accounts have been prepared on a going concern basis as set out in the Directors Report on page 38 of the annual report and in accordance with UK adopted international accounting standards.

 

The directors have carefully considered the issue of going concern in view of the Company's activities and associated risks. The Company has a well-diversified portfolio with businesses in a variety of sectors, many of which are well funded. Some portfolio companies may require additional funding in the near- to medium-term; the Company is well placed to provide this, where appropriate.

 

The Company has a significant level of liquidity, which will be further enhanced by the current fundraising. In addition, the Board has control over, and can flex as appropriate, the Company's major outgoings, which predominantly comprise investments, dividends and share buy-backs.

 

The directors have also assessed whether material uncertainties exist and their potential impact on the Company's ability to continue as a going concern; they have concluded that no such material uncertainties exist.

 

Taking all of the above into consideration, the directors are satisfied that the Company has sufficient resources to meet its obligations for at least 12 months from the date of this report and therefore believe that it is appropriate to continue to apply the going concern basis of accounting in preparing the financial statements.

 

The financial statements have been prepared under the historical cost basis as modified by the measurement of investments at fair value through profit or loss.

 

The accounts have been prepared in compliance with the recommendations set out in the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' issued by the Association of Investment Companies (issued in July 2022 - the "SORP") to the extent that they do not conflict with UK adopted international accounting standards.

 

The financial statements are prepared in accordance with UK adopted international accounting standards (International Financial Reporting Standards ("IFRS") and International Accounting Standards ("IAS")) and interpretations in force at the reporting date. From 1 January 2023 IAS 1 has been amended introducing the concept Material Accounting Policy Information. The Company has performed a review of its existing accounting policies and updated where relevant. Other new standards coming into force during the year and future standards that come into effect after the year-end have not had a material impact on these financial statements.

 

The Company has carried out an assessment of accounting standards, amendments and interpretations that have been issued by the IASB and that are effective for the current reporting period. The Company has determined that the transitional effects of the standards do not have a material impact.

 

The financial statements are presented in sterling and all values are rounded to the nearest thousand (£000), except where stated:

 

Financial Assets held at Fair Value through Profit or Loss - Investments

Financial assets designated as at fair value through profit or loss ("FVPL") at inception are those that are managed and whose performance is evaluated on a fair value basis, in accordance with the documented investment strategy of the Company. Information about these financial assets is provided internally on a fair value basis to the Company's key management. The Company's investment strategy is to invest cash resources in venture capital investments as part of the Company's long-term capital growth strategy. Consequently, all investments are classified as held at fair value through profit or loss.

 

All investments are measured at fair value on the whole unit of account basis with gains and losses arising from changes in fair value being included in the Statement of Comprehensive Income as gains or losses on investments held at fair value. Accrued income on loans/preference shares that is rolled to exit and is not yet past due, forms part of the investment's fair value.

 

Transaction costs on purchases are expensed immediately through profit or loss.

 

Although the Company holds more than 20 per cent of the equity of certain companies, it is considered that the investments are held as part of the investment portfolio, and their value to the Company lies in their marketable value as part of that portfolio. These investments are therefore not accounted for using equity accounting, as permitted by IAS 28 'Investments in associates' and IFRS 11 'Joint arrangements' which give exemptions from equity accounting for venture capital organisations.

 

Under IFRS 10 "Consolidated Financial Statements", control is presumed to exist when the Company has power over an investee (whether or not used in practice); exposure or rights; to variable returns from that investee, and ability to use that power to affect the reporting entities returns from the investees. The Company does not hold more than 50 per cent of the equity of any of the companies within the portfolio. The Company does not control any of the companies held as part of the investment portfolio. It is not considered that any of the holdings represent investments in subsidiary undertakings.

 

Valuation of Investments

Unquoted investments are valued in accordance with IFRS 13 "Fair Value Measurement" and using the International Private Equity and Venture Capital Valuation Guidelines (the "IPEV Guidelines"). Quoted investments are valued at market bid prices. A detailed explanation of the valuation policies of the Company is included below.

 

Initial Measurement

The best estimate of the initial fair value of an unquoted investment is the cost of the investment. Unless there are indications that this is inappropriate, an unquoted investment will be held at this value within the first three months of investment.

 

Subsequent Measurement

Based on the IPEV Guidelines we have identified six of the most widely used valuation methodologies for unquoted investments. The IPEV Guidelines advocate that the best valuation methodologies are those that draw on external, objective market-based data in order to derive a fair value.

 

Unquoted Investments

? Revenue multiples. An appropriate multiple, given the risk profile and revenue growth prospects of the underlying company, is applied to the revenue of the company. The multiple is adjusted to reflect any risk associated with lack of marketability and to take account of the differences between the investee company and the benchmark company or companies used to derive the multiple.

? Earnings multiple. An appropriate multiple, given the risk profile and earnings growth prospects of the underlying company, is applied to the maintainable earnings of the company. The multiple is adjusted to reflect any risk associated with lack of marketability and to take account of the differences between the investee company and the benchmark company or companies used to derive the multiple.

? Net assets. The value of the business is derived by using appropriate measures to value the assets and liabilities of the investee company.

? Discounted cash flows of the underlying business. The present value of the underlying business is derived by using reasonable assumptions and estimations of expected future cash flows and the terminal value, and discounted by applying the appropriate risk-adjusted rate that quantifies the risk inherent in the company.

? Discounted cash flows from the investment. Under this method, the discounted cash flow concept is applied to the expected cash flows from the investment itself rather than the underlying business as a whole.

? Price of recent investment. This may represent the most appropriate basis where a significant amount of new investment has been made by an independent third party. This is adjusted, if necessary, for factors relevant to the background of the specific investment such as preference rights and will be benchmarked against other valuation techniques. In line with the IPEV Guidelines the price of recent investment will usually only be used for the initial period following the round and after this an alternative basis will be found.

 

Due to the significant subjectivity involved, discounted cash flows are only likely to be reliable as the main basis of estimating fair value in limited situations. Their main use is to support valuations derived using other methodologies and for assessing reductions in fair value.

 

One of the valuation methods described above is used to derive the gross attributable enterprise value of the company after which adjustments are then made to reflect specific circumstances. This value is then apportioned appropriately to reflect the respective debt and equity instruments in the event of a sale at that level at the reporting date.

 

Listed Investment Funds

Listed investment funds are valued at active market bid price. An active market is defined as one where transactions take place regularly with sufficient volume and frequency to determine price on an ongoing basis. There were no listed investment funds held at 31 December 2023.

 

Income

Dividends and interest are received from financial assets measured at fair value through profit and loss and are recognised on the same basis in the Statement of Comprehensive Income. This includes interest and preference dividends rolled up and/or payable at redemption. Interest income is also received on cash, cash equivalents and current asset investments. Dividend income from unquoted equity shares is recognised at the time when the right to the income is established.

 

Expenses

Expenses are accounted for on an accruals basis. Expenses are charged through the Revenue column of the Statement of Comprehensive Income, except for the Manager's fee and incentive fees. Of the Manager's fees 75 per cent are allocated to the Capital column of the Statement of Comprehensive Income, to the extent that these relate to an enhancement in the value of the investments and in line with the Board's expectation that over the long term 75 per cent of the Company's investment returns will be in the form of capital gains. The incentive fee payable to the Manager (as set out in note 3) is charged wholly through the Capital column.

 

Tax relief is allocated to the Capital Reserve using a marginal basis.

 

Incentive Fee

The incentive fee is accounted for on an accruals basis. As further detailed in note 3, the incentive fee is calculated as 20 per cent of the amount by which the cumulative dividends per ordinary share paid as at the last business day in December in any year, plus the average of the Company's middle market price per ordinary share on the five dealing days prior to that day, exceeds the Hurdle (as defined in note 3), multiplied by the number of ordinary shares issued and the ordinary shares under option. At the end of each reporting period, an accrual is recognised based upon the cumulative dividends per ordinary share paid to the reporting date, plus the average of the Company's middle market price per ordinary share on the five dealing days prior to the reporting date. The incentive fee is charged wholly through the Capital column.

 

Cash, Cash Equivalents and Current Asset Investments

Cash at bank comprises cash at hand and bank deposits with an original maturity of less than three months, readily convertible to a known amount of cash and subject to an insignificant risk of changes in value.

 

Current asset investments comprise money market funds and balances held in fixed term deposits which mature after three months.

 

Cash and cash equivalents include cash at hand, money market funds and bank deposits repayable on up to three months' notice as these meet the definition in IAS 7 'Statement of cash flows' of a short-term highly liquid investment that is readily convertible into known amounts of cash and subject to insignificant risk of change in value.

 

Balances held in fixed term deposits which mature after three months are not classified as cash and cash equivalents, as they do not meet the definition in IAS 7 'Statement of cash flows' of short-term highly liquid investments.

 

Cash and cash equivalents are valued at amortised cost, which equates to fair value.

 

Cash flows classified as "operating activities" for the purposes of the Statement of Cash Flows are those arising from the Revenue column of the Statement of Comprehensive Income, together with the items in the Capital column that do not fall to be easily classified under the headings for "investing activities" given by IAS 7 'Statement of cash flows', being management and incentive fees payable to the Manager. The capital cash flows relating to the acquisition and disposal of investments are presented under "investing activities" in the Statement of Cash Flows in line with both the requirements of IAS 7 and the positioning given to these headings by general practice in the industry.

 

Share Capital and Reserves

Share Capital

This reserve contains the nominal value of all shares allotted under offers for subscription.

 

Share Premium Account

This reserve contains the excess of gross proceeds less issue costs over the nominal value of shares allotted under offers for subscription, to the extent that it has not been cancelled.

 

Capital Reserve

The following are included within this reserve:

? Gains and losses on realisation of investments;

? Realised losses upon permanent diminution in value of investments;

? Capital income from investments;

? 75 per cent of the Manager's fee expense, together with the related taxation effect to this reserve in accordance with the policy on expenses in note 1 of the financial statements;

? Incentive fee payable to the Manager;

? Capital dividends paid to shareholders;

? Applicable share issue costs;

? Purchase and holding of the Company's own shares; and

? Credits arising from the cancellation of any share premium account.

Investment Holding Gains and Losses Reserve

Increases and decreases in the valuation of investments held at the year end are accounted for in this reserve, except to the extent that the diminution is deemed permanent.

 

Revenue Reserve

This reserve includes all revenue income from investments along with any costs associated with the running of the Company - less 75 per cent of the Manager's fee expense as detailed in the Capital Reserve above.

 

Taxation

Due to the Company's status as a venture capital trust and the continued intention to meet the conditions required to comply with Chapter 3 Part 6 of the Income Tax Act 2007, no provision for taxation is required in respect of any realised or unrealised appreciation of the Company's investments which arises. Deferred tax is recognised on all temporary differences that have originated, but not reversed, by the balance sheet date.

 

Deferred tax assets are only recognised to the extent that they are regarded as recoverable. Deferred tax is calculated at the tax rates that are expected to apply when the asset is realised. Deferred tax assets and liabilities are not discounted.

 

Dividends Payable

Dividends payable are recognised only when an obligation exists. Interim and special dividends are recognised when paid and final dividends are recognised when approved by shareholders in general meetings.

 

Segmental Reporting

In accordance with IFRS 8 'Operating Segments' and the criteria for aggregating reportable segments, segmental reporting has been determined by the directors based upon the reports reviewed by the Board. The directors are of the opinion that the Company has engaged in a single operating segment - investing in equity and debt securities within the United Kingdom - and therefore no reportable segmental analysis is provided.

 

Critical Accounting Estimates and Judgements

The preparation of financial statements in conformity with generally accepted accounting practice requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management's best knowledge of the amount, event or actions, actual results may ultimately differ from those estimates. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are those used to determine the fair value of investments at fair value through profit or loss, as disclosed in note 7 to the financial statements.

 

The fair value of investments at fair value through profit or loss is determined by using valuation techniques. As explained above, the Board uses its judgement to select from a variety of methods and makes assumptions that are mainly based on market conditions at each balance sheet date.

 

The Board uses its judgement to select the appropriate method for determining the fair value of investments through profit or loss.

 

2. Income

2023

£000

2022

£000

Dividends from unquoted companies

531

642

Interest on loans to unquoted companies

152

206

Income from unquoted portfolio

683

848

Income from listed investment funds

47

22

Income from investments held at fair value through profit or loss

730

870

Interest from bank deposits/money market funds

1,317

205

2,047

1,075

 

3. Administrative Expenses

2023

£000

2022

£000

Manager's fee

2,147

1,786

Administration fee

85

75

Total payable to YFM Private Equity Limited

2,232

1,861

Incentive fee

1,601

635

Other expenses:

 

General expenses

135

120

Directors' remuneration

112

106

Listing and registrar fees

93

68

Trail commission

75

59

Auditor's remuneration - audit fees (excluding irrecoverable VAT)

63

62

Printing

57

40

Irrecoverable VAT

49

43

4,417

2,994

Fair value movement related to credit risk

-

(299)

4,417

2,695

Ongoing charges figure

2.14%

2.08%

 

Directors' remuneration comprises only short term benefits including social security contributions of £10,000 (2022: £10,000).

 

The directors are the Company's only key management personnel.

 

No fees are payable to the auditor in respect of other services (2022: £nil).

 

YFM Private Equity Limited has acted as Manager and performed administrative and secretarial duties for the Company under an Investment Agreement dated 28 November 2000, superseded by an agreement dated 31 October 2005 and as varied by agreements dated 8 December 2010, 26 October 2011, 16 November 2012, 17 October 2014, 7 August 2015 and 13 November 2019 (the "IA"). The agreement may be terminated by not less than twelve months' notice given by either party at any time. Under an Investment Agreement dated 13 November 2019, YFM Private Equity Limited was appointed as the Company's Alternative Investment Fund Manager. On 19 September 2023 YFM Private Equity Limited was approved as a full-scope Alternative Investment Fund Manager, from this date Thompson Taraz Depositary Limited were appointed as the Depositary and assumed responsibility for asset safekeeping, cash flow monitoring and oversight duties.

 

The key features of the agreement are:

? YFM Private Equity Limited receives a Manager's fee, payable quarterly in advance, calculated at half-yearly intervals as at 30 June and 31 December. The fee is allocated between capital and revenue as described in note 1;

? The annual Manager's fee payable to the Manager is 1.0 per cent on all surplus cash, defined as all cash above £5 million. The annual fee on all other assets will be 2.0 per cent of net assets per annum. Based on the Company's net assets at 31 December 2023 of £135,616,000, and cash and cash equivalents of £39,071,000 at that date this equates to approximately £2,372,000 per annum;

? YFM Private Equity Limited shall bear the annual operating costs of the Company (including the Manager's fee set out above but excluding any payment of the performance incentive fee, details of which are set out below and excluding VAT and trail commissions) to the extent that those costs exceed 2.9 per cent of the net asset value of the Company; and

? Under the IA, YFM Private Equity Limited also provides administrative and secretarial services to the Company for a fee of £46,000 per annum plus annual adjustments to reflect movements in the Retail Prices Index. This fee is charged fully to revenue, and totalled £85,000 for the year ended 31 December 2023 (2022: £75,000).

When the Company makes investments into its unquoted portfolio, the Manager charges that investee an advisory fee. With effect from 1 October 2013, if the average of relevant fees exceeds 3.0 per cent of the total invested into new portfolio companies and 2.0 per cent into follow-on investments over the Company's financial year, this excess will be rebated to the Company. As at 31 December 2023, the Company was due a rebate from the Manager of £nil (2022: £nil).

 

Monitoring and directors' fees the Manager receives from the investee companies are limited to a maximum of £40,000 (excluding VAT) per annum per company.

 

The total remuneration payable to YFM Private Equity Limited under the IA in the year was £2,232,000 (2022: £1,861,000).

 

Under the IA, YFM Private Equity Limited is entitled to receive fees from investee companies in respect of the provision of non-executive directors and other advisory services. YFM Private Equity Limited is responsible for paying the due diligence and other costs incurred in connection with proposed investments which for whatever reason do not proceed to completion. In the year ended 31 December 2023, the fees receivable by YFM Private Equity Limited from investee companies which were attributable to advisory and directors' and monitoring fees amounted to £1,869,000 (2022: £2,026,000).

 

Under the Subscription Rights Agreement dated 23 November 2001 between the Company, YFM Private Equity Limited and Chord Capital Limited ("Chord" formerly Generics Asset Management Limited), as amended by an agreement between those parties dated 31 October 2005, YFM Private Equity Limited and Chord have a performance-related incentive, structured so as to entitle them to an amount equivalent to 20 per cent of the amount by which the cumulative dividends per ordinary share paid as at the last business day in December in any year, plus the average of the middle market price per ordinary share on the five dealing days prior to that day (the "Share Price"), exceeds 120 pence per ordinary share, multiplied by the number of ordinary shares issued and the ordinary shares under option (if any) (the "Hurdle"). Under the terms of the Subscription Rights Agreement, once the Hurdle has been exceeded it is reset at that value going forward, which becomes the new Hurdle. Any subsequent exercise of these rights will only occur once the new Hurdle has been exceeded. The subscription rights are exercisable in the ratio 95:5 between the Manager and Chord Capital Limited.

 

By a Deed of Assignment dated 19 December 2003 (together with a supplemental agreement dated 5 October 2005), the benefit of the YFM Private Equity Limited subscription right was assigned to YFM Private Equity Limited Carried Interest Trust (the "Trust"), an employee benefit trust formed for the benefit of certain employees of YFM Private Equity Limited and associated companies. Pursuant to a deed of variation dated 16 November 2012 between the Company, the trustees of the Trust and Chord, the Subscription Rights Agreement was varied so that the subscription rights will be exercisable in the ratio of 95:5 between the trustees of the Trust and Chord. Pursuant to a deed of variation dated 5 August 2014 the Subscription Rights Agreement was varied so that the recipient was changed from the Trust to YFM Private Equity Limited. Pursuant to a deed of variation dated 13 November 2019 the Subscription Rights Agreement was varied so that the recipients can elect to receive the incentive in the form of shares or cash.

 

As at 31 December 2022, the total of cumulative cash dividends paid and the Share Price was 137.25 pence per ordinary share. Consequently the Hurdle was exceeded and a performance related incentive of £635,000 for the year ended 31 December 2022 was paid. The Hurdle for the year ending 31 December 2023 was reset at 137.25 pence per ordinary share.

 

As at 31 December 2023 the total of cumulative cash dividends paid and the Share Price was 140.75 pence per ordinary share. Consequently the Hurdle was exceeded and a performance related incentive of £1,601,000 for the year ended 31 December 2023 is payable.

 

The Company, the Manager and Chord have agreed to amend the current agreement with effect from 1 January 2024. The Hurdle for each financial year will be increased by an agreed percentage of the corresponding Share Price for each of the five years starting from the year ending 31 December 2024, commencing with 1 per cent for the year ending 31 December 2024 and increasing by an additional 1 per centage point per year until the year ending 31 December 2028 when the increase to the Hurdle will be 5 per cent of the corresponding Share Price. Following the changes, the Hurdle for the year ending 31 December 2024 was reset at 141.295 pence per ordinary share. In addition, from 1 January 2027 the subscription rights will be wholly exercisable to the Manager.

 

If the IA is terminated, the beneficiaries of the Incentive Agreement will continue to be entitled to the Incentive Payment. The Incentive Payment will be modified so as to entitle the recipients to an Incentive Payment that is fair, having regard to all the circumstances.

 

Under the terms of the offer launched with British Smaller Companies VCT plc on 30 November 2022, YFM Private Equity Limited was entitled to 3.0 per cent of gross subscriptions, (3.5 per cent for Applications received from Applicants who did not invest their money through a financial intermediary advisor and invested directly into the Company) less commissions payable to an execution-only broker or platform. The net amount paid to YFM Private Equity Limited under this offer amounted to £859,000.

 

Under the terms of the offer launched with British Smaller Companies VCT plc on 20 September 2023, YFM Private Equity Limited will be entitled to 3.0 per cent of gross subscriptions, (3.5 per cent for Applications received from Applicants who did not invest their money through a financial intermediary advisor and invested directly into the Company) less commissions payable to an execution-only broker or platform.

 

The details of directors' remuneration are set out in the Directors' Remuneration Report on page 50 of the annual report under the heading "Directors' Remuneration for the year ended 31 December 2023 (audited)".

?

4. Taxation

2023

2022

Revenue

£000

Capital

£000

Total

£000

Revenue

£000

Capital

£000

Total

£000

Profit before taxation

842

5,849

6,691

354

5,899

6,253

Profit before taxation multiplied by standard rate of corporation tax in UK of 19% (2022: 19%)

160

1,111

1,271

67

1,121

1,188

Effect of:

 

 

 

UK dividends received

(101)

-

(101)

(172)

-

(172)

Non-taxable profits on investments

-

(1,721)

(1,721)

-

(1,496)

(1,496)

Deferred tax not recognised

(59)

610

551

105

375

480

Tax charge

-

-

-

-

-

-

 

The Company has no provided or unprovided deferred tax liability in either year.

 

Deferred tax assets of £4,420,000 (2022: £3,703,000) calculated at 25% (2022: 25%) in respect of unrelieved management expenses (£17.68 million as at 31 December 2023 and £14.81 million as at 31 December 2022) have not been recognised as the directors do not currently believe that it is probable that sufficient taxable profits will be available against which assets can be recovered.

 

Due to the Company's status as a venture capital trust and the continued intention to meet with the conditions required to comply with Section 274 of the Income Tax Act 2007, the Company has not provided for deferred tax on any capital gains or losses arising on the revaluation or realisation of investments.

 

5. Dividends

Amounts recognised as distributions to equity holders in the period to 31 December:

 

2023

2022

Revenue

£000

Capital

£000

Total

£000

Revenue

£000

Capital

£000

Total

£000

Interim dividend for the year ended 31 December 2023 of 2.25p (2022: 1.5p) per ordinary share

-

4,097

4,097

-

2,718

2,718

Second interim dividend for the year ended 31 December 2023 of 1.5p (2022: 1.5p) per ordinary share

301

3,130

3,431

-

2,726

2,726

Third interim dividend for the year ended 31 December 2023 of 1.5p per ordinary share

-

3,428

3,428

-

-

-

301

10,655

10,956

-

5,444

5,444

Proceeds from shares allotted under DRIS

 

 

(2,083)

(1,085)

Dividends paid in Statement of Cash Flows

 

 

8,873

4,359

 

The first interim dividend of 2.25 pence per ordinary share was paid on 11 January 2023 to shareholders on the register as at 18 November 2022.

 

The second interim dividend of 1.5 pence per ordinary share was paid on 26 June 2023 to shareholders on the register as at 12 May 2023.

 

The third interim dividend of 1.5 pence per ordinary share was paid on 3 November 2023 to shareholders on the register as at 6 October 2023.

 

An interim dividend of 1.5 pence per ordinary share, in respect of the year ending 31 December 2024, will be paid on 28 June 2024 to shareholders on the register on 31 May 2024. This dividend was not recognised in the year ended 31 December 2023 as the obligation did not exist at the balance sheet date.

 

6. Basic and Diluted Earnings per Ordinary Share

The basic and diluted earnings per ordinary share is based on the profit after tax attributable to shareholders of £6,691,000 (2022: £6,253,000) and 217,157,606 (2022: 181,163,554) ordinary shares being the weighted average number of ordinary shares in issue during the year.

 

The basic and diluted revenue earnings per ordinary share is based on the revenue profit for the year attributable to shareholders of £842,000 (2022: £354,000) and 217,157,606 (2022: 181,163,554) ordinary shares being the weighted average number of ordinary shares in issue during the year.

 

The basic and diluted capital earnings per ordinary share is based on the capital profit for the year attributable to shareholders of £5,849,000 (2022: £5,899,000) and 217,157,606 (2022: 181,163,554) ordinary shares being the weighted average number of ordinary shares in issue during the year.

 

During the year the Company allotted 3,649,583 new ordinary shares in respect of its DRIS and 46,357,328 new ordinary shares from the fundraising.

The Company has also repurchased 2,716,956 of its own shares in the year, and these shares are held in the capital reserve. The total of 21,383,768 treasury shares has been excluded in calculating the weighted average number of ordinary shares for the period. The Company has no securities that would have a dilutive effect and hence basic and diluted earnings per ordinary share are the same.

 

The Company has no potentially dilutive shares and consequently, basic and diluted earnings per ordinary share are equivalent in both the year ended 31 December 2023 and 31 December 2022.

 

7. Financial Assets at Fair Value through Profit or Loss - Investments

 

2023

£000

2022

£000

Investment portfolio

96,427

82,981

Accrued income and other assets

1,275

-

Financial assets at fair value through profit and loss

97,702

82,981

 

IFRS 13, in respect of financial instruments that are measured in the balance sheet at fair value, requires disclosure of fair value measurements by level of the following fair value measurement hierarchy:

 

Level 1: quoted prices in active markets for identical assets or liabilities. The fair value of financial instruments traded in active markets is based on quoted market prices at the balance sheet date. An active market is defined as a market in which transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis. The quoted market price used for financial assets held by the Company is the current bid price. These instruments are included in level 1 and comprise fixed income securities classified as held at fair value through profit or loss. The Company held no such investments at 31 December 2023.

 

Level 2: the fair value of financial instruments that are not traded in an active market is determined by using valuation techniques. These valuation techniques maximise the use of observable market data where it is available and rely as little as possible on entity specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is included in level 2. The Company held no such instruments in the current or prior year.

 

Level 3: the fair value of financial instruments that are not traded in an active market (for example, investments in unquoted companies) is determined by using valuation techniques such as revenue and earnings multiples. If one or more of the significant inputs is not based on observable market data, the instrument is included in level 3. All of the Company's investments fall into this category at 31 December 2023.

 

Each investment is reviewed at least quarterly to ensure that it has not ceased to meet the criteria of the level in which it is included at the beginning of each accounting period. The change in fair value for the current and previous year is recognised through profit or loss.

 

There have been no transfers between these classifications in either period.

 

All items held at fair value through profit or loss were designated as such upon initial recognition.

 

Valuation of Investments

Full details of the methods used by the Company are set out in note 1 of these financial statements. Where investments are held in listed investment funds, fair value is set at the market bid price.

Movements in investments at fair value through profit or loss during the year to 31 December 2023 are summarised as follows:

 

IFRS 13 measurement classification

Level 3

Unquoted

Investments

Level 1

Listed

Investment

Funds

Total

Investments

£000

£000

£000

Opening cost

49,494

1,752

51,246

Opening investment holding gain (loss)*

31,891

(156)

31,735

Opening fair value at 1 January 2023

81,385

1,596

82,981

Additions at cost

10,031

665

10,696

Disposal proceeds

(4,125)

(2,159)

(6,284)

Net profit on disposal**

1,093

(102)

991

Change in fair value

9,258

-

9,258

Foreign exchange loss

(1,215)

-

(1,215)

Closing fair value at 31 December 2023

96,427

-

96,427

Closing cost

56,209

-

56,209

Closing investment holding gain*

40,218

-

40,218

Closing fair value at 31 December 2023

96,427

-

96,427

* Following the merger between the Company and British Smaller Technologies Company VCT plc a total of £975,000 of negative goodwill was recognised in the investment holding gains and losses reserve in respect of the investments acquired. The relevant amount per investment is realised at the point of disposal to the capital reserve. At 31 December 2023 a total of £27,000 (2022: £27,000) was held on investments yet to be realised in the investment holdings gains and losses reserve.

** The net profit on disposal in the table above is £991,000 whereas that shown in the Statement of Comprehensive Income is £1,018,000. The difference comprises deferred proceeds in respect of assets which have been disposed of in prior periods and were not included in the portfolio at 1 January 2023.

 

The following disposals took place in the year:

 

Net proceeds

from sale

 

Cost

 

Opening

carrying

value as at

1 January 2023

Profit (loss)

on disposal

 

£000

£000

£000

£000

Unquoted investments:

E2E Engineering Limited

1,305

600

800

505

Ncam Technologies Limited

1,118

1,675

1,175

(57)

Macro Art Holdings Limited

990

320

409

581

Wakefield Acoustics (via Malvar Engineering Limited)

712

720

648

64

Total from portfolio

4,125

3,315

3,032

1,093

Tissuemed Limited

27

-

-

27

Deferred Consideration

27

-

-

27

Listed investment funds*

2,159

2,418

2,261

(102)

Total from investment portfolio**

6,311

5,733

5,293

1,018

 

* Opening carrying value includes further investments made during the year.

** The total from disposals in the year in the table above is £6,311,000 whereas that shown in total in the Statement of Cash Flows is £6,058,000. The difference comprises deferred proceeds of £253,000 which will be received in subsequent years.

 

8. Basic and Diluted Net Asset Value per Ordinary Share

The basic and diluted net asset value per ordinary share is calculated on attributable assets of £135,616,000 (2022: £111,869,000) and 228,758,665 (2022: 181,468,710) ordinary shares in issue at the year end.

 

The treasury shares have been excluded in calculating the number of ordinary shares in issue at 31 December 2023.

 

The Company has no potentially dilutive shares and consequently, basic and diluted net asset values per ordinary share are equivalent in both the years ended 31 December 2023 and 31 December 2022.

?

9. Total Return per Ordinary Share

The Total Return per ordinary share is calculated on cumulative dividends paid of 86.25 pence per ordinary share (2022: 81.0 pence per ordinary share) plus the net asset value as calculated per note 8.

 

10. Financial Commitments

There are no financial commitments at 31 December 2023 or 31 December 2022.

 

11. Events after the Balance Sheet Date

Having previously assessed its expected cash requirements, the Company announced a new share offer on 20 September 2023, alongside British Smaller Companies VCT plc, with the intention of raising up to £90 million, in aggregate which included an over-allotment facility of £25 million, in aggregate. The offers closed to new Applications on 16 February 2024. Gross Applications of £90 million have been received, of which £34.5 million relate to the Company. The first allotment of £30 million (£11.4 million relating to the Company) took place on 30 January 2024. The second and final allotment will take place in early April 2024.

 

Subsequent to the year end, the Company has invested £1.2 million into three follow on investments. The Company also received £6.5 million from the realisation of Displayplan, and the partial realisations of KeTech and Arcus, as detailed above.

 

On 30 January 2024, the Company issued 19,533,372 shares in relation to the 2023/24 fundraising, raising gross proceeds of £11.4 million. Following this allotment, the Company's issued share capital consists of 248,292,037 ordinary shares with voting rights and 21,383,768 shares held in treasury.

 

12. Contingent liability

As set out in note 3, the Manager and Chord Capital are entitled to a performance-related incentive fee if the cumulative dividends per ordinary share paid as at the last business day of December in any year plus the average of the middle market price per ordinary share on the five dealing days prior to that day, exceeds a Hurdle, which is set at 141.295 pence per ordinary share for the year ending 31 December 2024. The value of the incentive fee is 20 per cent of the excess to the Hurdle, multiplied by the number of ordinary shares issued. The reported net assets per ordinary share have increased by 2.4 pence per ordinary share since 31 December 2023. If this increase were to flow through to an increase in the middle market price per ordinary share in the last five dealing days of December 2024, at a discount of 5 per cent to the net asset value per ordinary share, then an incentive fee of approximately £641,000 would be payable at 31 December 2024 based on the number of shares in issue at 15 March 2024.

 

13. Related Party Transactions

Fees payable during the year to the directors and their interests in the shares of the Company are disclosed within the Directors' Remuneration Report on page 50 of the annual report. There were no amounts outstanding and due to the directors at 31 December 2023 (2022: £nil).

 

14. Annual Report and Accounts

Copies of the statutory accounts for the year ended 31 December 2023 will shortly be submitted to the National Storage Mechanism and will be available to the public for viewing online at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. They can also shortly be viewed on the Company's website at www.bscfunds.com. Hard copies of the statutory accounts for the year to 31 December 2023 will be distributed by post or electronically to shareholders and will thereafter be available to members of the public from the Company's registered office.

15. Directors

The directors of the Company are Mr P C Waller, Ms B L Anderson and Mr R S McDowell.

16. Annual General Meeting

The Annual General Meeting of the Company will be held at 9:30 am on 13 June 2024 at Thomas House, 84 Ecclestone Square, London SW1V 1PX. Full details of the agenda for this meeting are included in the Notice of the Annual General Meeting on page 90 of the annual report.

 

17. Interim Dividend for the Year Ending 31 December 2024

The directors are pleased to announce the payment of an interim dividend for the year ending 31 December 2024 of 1.5 pence per ordinary share ("Interim Dividend").

 

The Interim Dividend will be paid on 28 June 2024 to those shareholders on the Company's register at the close of business on 31 May 2024. The ex-dividend date will be 30 May 2024.

 

The directors are not proposing a final dividend for the year ended 31 December 2023.

 

18. Dividend Re-investment Scheme

The Company operates a dividend re-investment scheme ("DRIS"). The latest date for receipt of new or updated DRIS elections in respect of the Interim Dividend is the close of business on 14 June 2024.

 

19. Inside Information

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

For further information, please contact:

 

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR QKPBPDBKDQND
Date   Source Headline
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20247:57 amRNSIssue of Equity and Close of Offers
26th Mar 202411:10 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:40 amRNSAppointment of non-executive Director
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNSAnnual Financial Report
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:26 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSIssue of Equity
18th Dec 20234:04 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
24th Nov 20237:00 amRNS3rd Quarter Results
3rd Nov 20239:40 amRNSPayment of dividend and issue of equity
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:16 amRNSTransaction in Own Shares
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
13th Sep 20237:00 amRNSHalf-year Report
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
27th Jun 20237:46 amRNSTransaction in Own Shares
26th Jun 202310:57 amRNSDirector/PDMR Shareholding
26th Jun 202310:56 amRNSPayment of Dividend and Issue of Equity
16th Jun 202312:00 pmRNS1st Quarter Results
15th Jun 20233:17 pmRNSResult of Meeting
15th Jun 20233:16 pmRNSResult of AGM
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:22 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:40 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
23rd Mar 202311:30 amRNSPublication of Circular
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNSAnnual Financial Report
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:50 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.